60

Bibliographie A. Literatur

1. Abuirjeie MA ; Irshaid YM ; Al Hadidi HF ; Rawashdeh NM . "Simultaneous high performance liquid chromatographic determination of dapsone and monoacetyldapsone in human plasma and urine. " J Clin Pharm Ther 1991 ; 16(4) : 247-55 .

2. Ahmad RA ; Rogers HJ . "Pharmacokinetics and protein binding interactions of dapsone and pyrimethamine. " Br J Clin Pharmacol 1980 ; 10(5) : 519-24 .

3. Alexander JO ; Young E .; McFadyen T .; Fraser NG ; Duguid WP ; Meredith EM . "Absorption and excretion of 35S dapsone in dermatitis herpetiformis. " Br J Dermatol 1970 ; 83(6) : 620-31 .

4. Allegra CJ ; Boarman D .; Kovacs JA ; Morrison P .; Beaver J .; Chabner BA ; Masur H . "Interaction of sulfonamide and sulfone compounds with Toxoplasma gondii dihydropteroate synthase. " J Clin Invest 1990 ; 85(2) : 371-9 .

5. Allegra CJ ; Kovacs JA ; Drake JC ; Swan JC ; Chabner BA ; Masur H . "Activity of antifolates against Pneumocystis carinii dihydrofolate reductase and identification of a potent new agent. " J Exp Med 1987 ; 165(3) : 926-31 .

6. Antinori A .; Murri R .; Ammassari A .; De Luca A .; Linzalone A .; Cingolani A .; Damiano F .; Maiuro G .; Vecchiet J .; Scoppettuolo G ; Tamburrini E ; Ortona L . "Aerosolized pentamidine, cotrimoxazole and dapsone pyrimethamine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis. " AIDS 1995 ; 9(12) : 1343-50 .

7. Antinori A .; Murri R .; Tamburrini E .; De Luca A .; Ortona L . "Failure of low dose dapsone pyrimethamine in primary prophylaxis of Pneumocystis carinii pneumonia. " Lancet 1992 ; 340(8822) : 788 .

61

8. Aronson JK ; Hardman M . "ABC of monitoring drug therapy. Patient compliance. " BMJ 1992 ; 305(6860) : 1009-11 .

9. Biggs JT ; Gordon GR ; Peters JH . "Disappearance rates and plasma protein binding of dapsone (DDS) and monoacetyldapsone (MADDS) in animals and man. " Federation Proceedings 1971 ; 30 : 629 .

10. Blum RN ; Miller LA ; Gaggini LC ; Cohn DL . "Comparative trial of dapsone versus trimethoprim/sulfamethoxazole for primary prophylaxis of Pneumocystis carinii pneumonia. " J Acquir Immune Defic Syndr 1992 ; 5(4) : 341-7 .

11. Bozzette SA ; Finkelstein DM ; Spector SA ; Frame P .; Powderly WG ; He W .; Phillips L .; Craven D .; Van der Horst C .; Feinberg J . "A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group. " N Engl J Med 1995 ; 332(11) : 693-9 .

12. Broughton MC ; Queener SF . "Pneumocystis carinii dihydrofolate reductase used to screen potential antipneumocystis drugs. " Antimicrob Agents Chemother 1991 ; 35(7) : 1348-55 .

13. Carr A .; Tindall B .; Brew BJ ; Marriott DJ ; Harkness JL ; Penny R .; Cooper DA . "Low dose trimethoprim sulfamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS. " Ann Intern Med 1992 ; 117(2) : 106-11 .

14. Carr K .; Oates JA ; Nies AS ; Woosley RL . "Simultaneous analysis of dapsone and monoacetyldapsone employing high performance liquid chromatography: a rapid method for determination of acetylator phenotype. " Br J Clin Pharmacol 1978 ; 6(5) : 421-7 .

15. Centers For Disease Control . "Guidelines for prophylaxis against Pneumocystis carinii pneumonia in patients infected with human immunodeficiency virus. " MMWR 1989 ; Supp S-5 : 1-9 .

62

16. Centers For Disease Control . 1993 "revised classification system for HIV infection and expanded surveillance case definition of AIDS among adolescents and adults. " MMWR 1992 ; 41 : RR-17 .

17. Chio LC ; Queener SF . "Identification of highly potent and selective inhibitors of Toxoplasma gondii dihydrofolate reductase. " Antimicrob Agents Chemother 1993 ; 37(9) : 1914-23 .

18. Coleman MD ; Edwards G .; Mihaly GW ; Howells RE ; Breckenridge AM . "High performance liquid chromatographic method for the determination of pyrimethamine and its 3 N oxide metabolite in biological fluids. " J Chromatogr 1984 ; 308(363-9) .

19. Cook IF ; Cochrane JP ; Edstein MD . "Race linked differences in serum concentrations of dapsone, monoacetyldapsone and pyrimethamine during malaria prophylaxis. " Trans R Soc Trop Med Hyg 1986 ; 80(6) : 897-901 .

20. Cramer JA ; Mattson RH ; Prevey ML . "How often is medication taken as prescribed? A novel assessment technique. " JAMA 1989 ; 261 : 3273-7 .

21. Cucinell SA ; Israili ZH ; Dayton PG . "Microsomal N oxidation of dapson as a cause of methemoglobin formation in human red cells. " Am J Trop Med Hyg 1972 ; 21(3) : 322-31 .

22. Cushion MT ; Stanforth D .; Linke MJ ; Walzer PD . "Method of testing the susceptibility of Pneumocystis carinii to antimicrobial agents in vitro. " Antimicrob Agents Chemother 1985 ; 28(6) : 796-801 .

23. Decker CF ; Masur H . "Current status of prophylaxis for opportunistic infections in HIV infected patients. " AIDS 1994 ; 8(1) : 11-20 .

24. Derouin F .; Chastang C . "In vitro effects of folate inhibitors on Toxoplasma gondii. " Antimicrob Agents Chemother 1989 ; 33(10) : 1753-9 .

63

25. Derouin F .; Piketty C .; Chastang C .; Chau F .; Rouveix B .; Pocidalo JJ . "Anti Toxoplasma effects of dapsone alone and combined with pyrimethamine. " Antimicrob Agents Chemother 1991 ; 35(2) : 252-5 .

26. Drayer DE ; Reidenberg MM . "Clinical consequences of polymorphic acetylation of basic drugs. " Clin Pharmacol Ther 1977 ; 22(3) : 251-8 .

27. Du Souich P .; Lambert C . "What is the clinical meaning of the acetylator phenotype? " Trend Pharmacol Scien 1981 ; 2 : 189-91 .

28. Edman JC ; Kovacs JA ; Masur H .; Santi DV ; Elwood HJ ; Sogin ML . "Ribosomal RNA sequence shows Pneumocystis carinii to be a member of the fungi. " Nature 1988 ; 334(6182) : 519-22 .

29. Edstein M . "Quantification of antimalarial drugs. II. Simultaneous measurement of dapsone, monoacetyldapsone and pyrimethamine in human plasma. " J Chromatogr 1984 ; 307(2) : 426-31 .

30. Edstein MD ; Rieckmann KH ; Veenendaal JR . "Multiple dose pharmacokinetics and in vitro antimalarial activity of dapsone plus pyrimethamine (Maloprim) in man. " Br J Clin Pharmacol 1990 ; 30(2) : 259-65 .

31. Eljaschewitsch J .; Padberg J .; Schürmann D .; Ruf B . "High-performance liquid chromatography determination of pyrimethamine, dapsone, monoacetyldapsone, sulfadoxine, and N-acetyl-sulfadoxine after rapid solid-phase extraction. " Ther Drug Monit 1996 ; 18 : 592-7 .

32. Endre ZH ; Charlesworth JA ; MacDonald GJ ; Woodbridge L . "Successful treatment of acute dapsone intoxication using charcoal hemoperfusion. " Aust N Z J Med 1983 ; 13(5) : 509-12 .

64

33. Falco EA ; Goodwin LG ; Hitchings GH ; Rollo IM ; Russell PB . "2:4-diaminopyrimidines - a new series of antimalarials. " Br J Pharmacol Chem 1951 ; 6 : 185-200 .

34. Fernandez-Martin J .; Leport C .; Morlat P et al. . " Pyrimethamine-Clarithromycin combination for therapy of acute toxoplasma encephalitis in patients with AIDS. " Antimicrob Agents Chemother 1991 ; 35 : 2049-52 .

35. Fischl MA ; Dickinson GM ; La Voie L . "Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS. " JAMA 1988 ; 259(8) : 1185-9 .

36. Fischl MA ; Parker CB ; Pettinelli C .; Wulfsohn M .; Hirsch MS ; Collier AC ; AntonIskis D .; Ho M .; Richman DD ; Fuchs E et al. . "A randomized controlled trial of a reduced daily dose of zidovudine in patients with the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group. " N Engl J Med 1990 ; 323(15) : 1009-14 .

37. Frenkel JK ; Hitchings GH . "Relative reversal by vitamins (p-aminobenzoic, folic and folinic acids) of the effects of sulfadiazine and pyrimethamine on Toxoplasma, mouse and man" . Antib Chemother 1957 ; 7 : 630-8 .

38. Garg SK ; Kumar B .; Bakaya V .; Lal R .; Shukla VK ; Kaur S . "Plasma dapsone and its metabolite monoacetyldapsone levels in leprotic patients. " Int J Clin Pharmacol Ther Toxicol 1988 ; 26(11) : 552-4 .

39. Gelber R .; Peters JH ; Gordon GR ; Glazko AJ ; Levy L . "The polymorphic acetylation of dapsone in man. " Clin Pharmacol Ther 1971 ; 12(2) : 225-38 .

40. Gelber RH ; Rees RJ . "Dapsone metabolism in patients with dapsone resistant leprosy. " Am J Trop Med Hyg 1975 ; 24(6 Pt 1) : 963-7 .

65

41. Gidoh M .; Tsutsumi S .; Takitani S . "Determination of three main antileprosy drugs and their main metabolites in serum by high performance liquid chromatography. " J Chromatogr; 1981 May 8 1981 ; 223(2) : 379-92 .

42. Girard PM ; Landman R .; Gaudebout C .; Olivares R .; Saimot AG ; Jelazko P .; Gaudebout C .; Certain A .; Boue F .; Bouvet E .; et al . "Dapsone pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. The PRIO Study Group. " N Engl J Med 1993 ; 328(21) : 1514-20 .

43. Glazko AJ ; Dill WA ; Montalbo RG ; Holmes EL . "A new analytical procedure for dapsone. Application to blood level and urinary excretion studies in normal men" . Am J Trop Med Hyg 1968 ; 17(3) : 465-73 .

44. Golden JA ; Katz MH ; Chernoff DN ; Duncan SM ; Conte JE Jr . "A randomized comparison of once monthly or twice monthly high dose aerosolized pentamidine prophylaxis" . Chest 1993 ; 104(3) : 743-50 .

45. Grant I .; Gold J .; Rosenblum M .; Niedzwiecki D .; Armstrong D . "Toxoplasma gondii serology in HIV infected patients: the development of central nervous system toxoplasmosis in AIDS" . AIDS 1990 ; 4(6) : 519-21 .

46. Grünewald T .; Bergmann F .; Eljaschewitsch J .; Pohle HD ; Ruf B . "Antiprotozoal prophylaxis in AIDS patients: results of a prospective randomized study comparing dapsone/pyrimethamine and sulfadoxine/pyrimethamine" . In: Progams and abstracts of the ninth International Conference on AIDS 1993 ; Abstract WS-B13-3.

47. Hanson A .; Melander A .; Wahlin Boll E . "Acetylator phenotyping: a comparison of the isoniazid and dapsone tests" . Eur J Clin Pharmacol 1981 ; 20(3) : 233-4 .

66

48. Hardy WD ; Feinberg J .; Finkelstein DM ; Power ME ; He W .; Kaczka C .; Frame PT ; Holmes M .; Waskin H .; Fass RJ ; et al . "A controlled trial of trimethoprim sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021" . N Engl J Med 1992 ; 327(26) : 1842-8 .

49. Hirschel B .; Lazzarin A .; Chopard P .; Opravil M .; Furrer HJ ; Ruttimann S .; Vernazza P .; Chave JP ; Ancarani F .; Gabriel V .; et al . "A controlled study of inhaled pentamidine for primary prevention of Pneumocystis carinii pneumonia" . N Engl J Med 1991 ; 324(16) : 1079-83 .

50. Hjelm M .; Verdier CH . "Biochemical effects of aromatic amines. I. Methaemoglobinaemia, haemolysis and Heinz body formation induced by 4,4' diaminodiphenylsulphone" . Biochem Pharmacol 1965 ; 14(7) : 1119-28 .

51. Horai Y .; Ishizaki T . "Rapid and sensitive liquid chromatographic method for the determination of dapsone and monoacetyldapsone in plasma and urine" . J Chromatogr 1985 ; 345(2) : 447-52 .

52. Horowitz HW ; Jorde UP ; Wormser GP . "Drug interactions in use of dapsone for Pneumocystis carinii prophylaxis" . Lancet 1992 ; 339(8795) : 747 .

53. Huengsberg M .; Castelino S .; Sherrard J .; O'Farrell N .; Bingham J . "Does drug interaction cause failure of PCP prophylaxis with dapsone?" . Lancet 1993 ; 341(8836) : 48 .

54. Hughes WT . "Opportunistic infections in AIDS patients. Current management and prevention" . Postgrad Med 1994 ; 95(1) : 81-93 .

55. Huikeshoven H . "Patient compliance with dapsone administration in leprosy" . Int J Lepr Other Mycobact Dis 1981 ; 49(2) : 228-58 .

67

56. Ioannidis JP ; Cappelleri JC ; Skolnik PR ; Lau J .; Sacks HS . "A meta analysis of the relative efficacy and toxicity of Pneumocystis carinii prophylactic regimens" . Arch Intern Med 1996 ; 156(2) : 177-88 .

57. Israelski DM ; Chmiel JS ; Poggensee L .; Phair JP ; Remington JS . "Prevalence of Toxoplasma infection in a cohort of homosexual men at risk of AIDS and toxoplasmic encephalitis " . J Acquir Immune Defic Syndr 1993 ; 6(4) : 414-8 .

58. Jensen BN ; Nielsen TL ; Backer V .; Nelsing S .; Simonsen L .; Flaschs H .; Gaub J .; HOjlyng N .; Nielsen JO ; Mathiesen L .; et al . "Aerosolized pentamidine for primary prophylaxis of Pneumocystis carinii pneumonia: a controlled randomized trial" . J Acquir Immune Defic Syndr 1993 ; 6(5) : 472-7 .

59. Jones CR ; Ovenell SM . "Determination of plasma concentrations of dapsone, monoacetyl dapsone and pyrimethamine in human subjects dosed with maloprim" . J Chromatogr 1979 ; 163(2) : 179-85 .

60. Karim AK ; Elfellah MS ; Evans DA . "Human acetylator polymorphism: estimate of allele frequency in Libya and details of global distribution" . J Med Genet 1981 ; 18(5) : 325-30 .

61. Kaufman HE ; Geisler PH . "The hematologic toxicity of pyrimethamine (Daraprim) in man" . Arch Ophthal 1960 ; 64 : 140-6 .

62. Kovacs JA " and the NIAID-clinical center intramural AIDS program : Efficacy of atovaquonein treatment of toxoplasmosis in patients with AIDS" . Lancet 1992 ; 340 : 637-8 .

63. Kovacs JA ; Allegra CJ ; Beaver J .; Boarman D .; Lewis M .; Parrillo JE ; Chabner B . "Masur H. Characterization of de novo folate synthesis in Pneumocystis carinii and Toxoplasma gondii: potential for screening therapeutic agents" . J Infect Dis 1989 ; 160(2) : 312-20 .

68

64. Kovacs JA ; Masur H . "Prophylaxis for Pneumocystis carinii pneumonia in patients infected with human immunodeficiency virus" . Clin Infect Dis 1992 ; 14(5) : 1005-9 .

65. Kruse W . "Patient compliance with drug treatment new perspectives on an old problem" . Clin Investig 1992 ; 70(2) : 163-6 .

66. Lee BL ; Medina I .; Benowitz NL ; Jacob P .; Wofsy CB ; Mills J . "Dapsone, trimethoprim, and sulfamethoxazole plasma levels during treatment of Pneumocystis pneumonia in patients with the acquired immunodeficiency syndrome (AIDS). Evidence of drug interactions" . Ann Intern Med 1989 ; 110(8) : 606-11 .

67. Lee HS ; Ti TY ; Lee PS ; Yap CL . "Simultaneous estimation of serum concentrations of dapsone, monoacetyldapsone, and pyrimethamine in Chinese men on maloprim for malaria prophylaxis using reversed phase high performance liquid chromatography" . Ther Drug Monit 1985 ; 7(4) : 415-20 .

68. Lemnge MM ; Ronn A .; Flachs H .; Bygbjerg IC . "Simultaneous determination of dapsone, monoacetyldapsone and pyrimethamine in whole blood and plasma by high performance liquid chromatography" . J Chromatogr 1993 ; 613(2) : 340-6 .

69. Lemp GF ; Payne SF ; Neal D .; Temelso T .; Rutherford GW . "Survival trends for patients with AIDS" . JAMA 1990 ; 263(3) : 402-6 .

70. Leoung GS ; Feigal DW Jr ; Montgomery AB ; Corkery K .; Wardlaw L .; Adams M .; Busch D .; Gordon S .; Jacobson MA ; Volberding PA ; et al . "Aerosolized pentamidine for prophylaxis against Pneumocystis carinii pneumonia. The San Francisco community prophylaxis trial" . N Engl J Med 1990 ; 323(12) : 769-75 .

71. Levy L .; Higgins LJ . "Dapsone assay based on Schiff base formation" . Int J Lepr Other Mycobact Dis 1966 ; 34(4) : 411-4 .

69

72. Luft BJ ; Remington JS . "Toxoplasmic encephalitis in AIDS" . Clin Infect Dis 1992 ; 15(2) : 211-22 .

73. Mallolas J .; Zamora L .; Gatell JM ; Miro JM ; Vernet E .; Valls ME ; Soriano E .; SanMiguel JG . "Primary prophylaxis for Pneumocystis carinii pneumonia: a randomized trial comparing cotrimoxazole, aerosolized pentamidine and dapsone plus pyrimethamine" . AIDS 1993 ; 7(1) : 59-64 .

74. Mannan CA ; Krol GJ ; Kho BT . "High speed liquid chromatographic analysis of dapsone and related compounds" . J Pharm Sci 1977 ; 66(11) : 1618-23 .

75. Masur H .; Ognibene FP ; Yarchoan R .; Shelhamer JH ; Baird BF ; Travis W .; Suffredini AF ; Deyton L .; Kovacs JA ; Falloon J .; et al . "CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection" . Ann Intern Med 1989 ; 111(3) : 223-31 .

76. May DG ; Porter JA ; Uetrecht JP ; Wilkinson GR ; Branch RA . "The contribution of N hydroxylation and acetylation to dapsone pharmacokinetics in normal subjects" . Clin Pharmacol Ther 1990 ; 48(6) : 619-27 .

77. May T .; Beuscart C .; Reynes J .; Marchou B .; Leclercq P .; Borsa Lebas F .; Saba J .; MIcoud M .; Mouton Y .; Canton P . "Trimethoprim, sulfamethoxazole versus aerosolized pentamidine for primary prophylaxis of Pneumocystis carinii pneumonia: a prospective, randomized, controlled clinical trial. LFPMI Study Group" . J Acquir Immune Defic Syndr 1994 ; 7(5) : 457-62 .

78. McCabe RE ; Oster S . "Current recommendations and future prospects in the treatment of toxoplasmosis" . Drugs 1989 ; 38(6) : 973-87 .

79. McLeod R .; Mack D .; Foss R .; Boyer K .; Withers S .; Levin S .; Hubbell J . "Levels of pyrimethamine in sera and cerebrospinal and ventricular fluids from infants treated for congenital toxoplasmosis. Toxoplasmosis Study Group" . Antimicrob Agents Chemother 1992 ; 36(5) : 1040-8 .

70

80. Merali S .; Zhang Y .; Sloan D .; Meshnick S . "Inhibition of Pneumocystis carinii dihydropteroate synthetase by sulfa drugs" . Antimicrob Agents Chemother 1990 ; 34(6) : 1075-8 .

81. Metroka CE ; Lewis NJ ; Jacobus DP . "Desensitization to dapsone in HIV positive patients" . JAMA 1992 ; 267(4) : 512 .

82. Meuwissen JH ; Tauber I .; Leeuwenberg AD ; Beckers PJ ; Sieben M . "Parasitologic and serologic observations of infection with Pneumocystis in humans" . J Infect Dis 1977 ; 136(1) : 43-9 .

83. Modderman ES ; Merkus FW ; Zuidema J .; Hilbers HW ; Warndorff T . "Dapsone levels after oral therapy and weekly oily injections in Ethiopian leprosy patients" . Int J Lepr Other Mycobact Dis 1983 ; 51(2) : 191-6 .

84. Montaner JSG ; Lawson LM ; Gervais A ;" Aerosol Pentamidine for secondary prophylaxis of AIDS-related Pneumocystis carinii pneumonia" . Ann Intern Med 1991 ; 114 : 948-53 .

85. Moss AR ; McCallum G .; Volberding PA ; Bacchetti P .; Dritz S . "Mortality associated with mode of presentation in the acquired immune deficiency syndrome" . J Natl Cancer Inst 1984 ; 73(6) : 1281-4 .

86. Murray JF Jr ; Gordon GR ; Gulledge CC ; Peters JH . "Chromatographic fluorometric analysis of antileprotic sulfones" . J Chromatogr 1975 ; 107(1) : 67-72 .

87. Neuvonen PJ ; Elonen E .; Mattila MJ . "Oral activated charcoal and dapsone elimination" . Clin Pharmacol Ther 1980 ; 27(6) : 823-7 .

71

88. Opravil M .; Hirschel B .; Lazzarin A .; Heald A .; Pechere M .; Ruttimann S .; Iten A .; Von Overbeck J .; Oertle D .; Praz G .; et al . "Once weekly administration of dapsone/pyrimethamine vs. aerosolized pentamidine as combined prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus infected patients" . Clin Infect Dis 1995 ; 20(3) : 531-41 .

89. Opravil M .; Joos B .; Luthy R . "Levels of dapsone and pyrimethamine in serum during once weekly dosing for prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis" . Antimicrob Agents Chemother 1994 ; 38(5) : 1197-9 .

90. Panisko DM ; Keystone JS . "Treatment of malaria - 1990" . Drugs 1990 ; 39(2) : 160-89

91. Paxton JW . "Pharmacogenetic polymorphism of drug metabolism" . N Z Med J 1984 ; 97(762) : 567-9 .

92. Peters JH ; Gordon GR ; Colwell WT Jr . "The fluorometric measurement of 4,4' diaminodiphenyl sulfone and its acetylated derivatives in plasma and urine" . J Lab Clin Med 1970 ; 76(2) : 338-48 .

93. Peters JH ; Murray JF Jr ; Gordon GR ; Gelber RH . "Dapsone in saliva and plasma of man" . Pharmacology 1981 ; 22(3) : 162-71 .

94. Peters JH ; Shepard CC ; Gordon GR ; Rojas AV ; Elizondo DS . "The incidence of DDS resistance in lepromatous patients in Costa Rica: their metabolic disposition of DDS" . Int J Leprosy 1978 . 44 : 143-51 .

95. Phair J .; Munoz A .; Detels R .; Kaslow R .; Rinaldo C .; Saah A . "The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. Multicenter AIDS Cohort Study Group " . N Engl J Med 1990 ; 322(3) : 161-5 .

72

96. Philip PA ; Roberts MS ; Rogers HJ . "A rapid method for determination of acetylation phenotype using dapsone" . Br J Clin Pharmacol 1984 ; 17(4) : 465-9 .

97. Pieters FA ; Vincken BJ ; Zuidema J . "Dapsone and monoacetyldapsone determined in serum and saliva by a sensitive high performance liquid chromatographic method with a single extraction step" . J Chromatogr 1987 ; 422(322-7) .

98. Pifer LL ; Hughes WT ; Stagno S .; Woods D . "Pneumocystis carinii infection: evidence for high prevalence in normal and immunosuppressed children" . Pediatrics 1978 ; 61(1) : 35-41 .

99. Podzamczer D .; Santin M .; Jimenez J .; Casanova A .; Bolao F .; Gudiol GR . "Thrice weekly cotrimoxazole is better than weekly dapsone pyrimethamine for the primary prevention of Pneumocystis carinii pneumonia in HIV infected patients" . AIDS 1993 ; 7(4) : 501-6 .

100. Pohle HD ; Eichenlaub D . "ZNS-Toxoplasmose bei AIDS-Patienten" . AIFO 1987 ; 3 : 122-35 .

101. Porter SB ; Sande MA . "Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome" . N Engl J Med 1992 ; 327(23) : 1643-8 .

102. Powell RD ; DeGowin RL ; Eppes RB ; McNamara JV ; Carson PE . "The antimalarial and hemolytic properties of 4,4 diaminodiphenyl sulfone (DDS)" . Int J Lepr Other Mycobact Dis 1967 ; 35(4) : 590-604 .

103. Pullar T .; Feely M . "Problems of compliance with drug treatment: new solutions? " Pharm J 1990 ; 245 : 213-5 .

104. Reidenberg MM ; Drayer DE ; Levy M .; Warner H . "Polymorphic acetylation procainamide in man" . Clin Pharmacol Ther 1975 ; 17(6) : 722-30 .

73

105. Remington JS ; Desmonts G . "Toxoplasmosis. In: Remington JS and Klein JO (Eds) Infectious disease of the fetus and newborn infant" . WB Saunders Philadelphia 1983 ; 143-263 .

106. Revesz K .; Schneider I . "Therapeutic use of dapsone in dermatitis herpetiformis (Duhring) and in certain inflammatory skin diseases" . Orv Hetil 1995 ; 136(2) : 59-62 .

107. Robert Koch-Institut für Infektionskrankheiten und nicht übertragbare Krankheiten . "122. Bericht des AIDS-Zentrums im Robert Koch-Institut über aktuelle epidemiologische Daten. Quartalsbericht" II/96

108. Rønn AM ; Lemnge MM ; Angelo HR ; Bygbjerg IC . "High performance liquid chromatography determination of dapsone, monoacetyldapsone, and pyrimethamine in filter paper blood spots" . Ther Drug Monit 1995 ; 17(1) : 79-83 .

109. Rothenberg R .; Woelfel M .; Stoneburner R .; Milberg J .; Parker R .; Truman B . "Survival with the acquired immunodeficiency syndrome. Experience with 5833 cases in New York City" . N Engl J Med 1987 ; 317(21) : 1297-302 .

110. Royce RA ; Luckmann RS ; Fusaro RE ; Winkelstein W . "Jr. The natural history of HIV 1 infection: staging classifications of disease" . AIDS 1991 ; 5(4) : 355-64 .

111. Rudd P .; Ahmed S .; Zachary V .; Barton C .; Bonduelle D . "Issues in patient compliance: the search for therapeutic sufficiency" . Cardiology 1992 ; 80 Supp : 1(2-10) .

112. Ruf B .; Schürmann D .; Bergmann F .; Schüler-Maue W .; Grünewald T .; Gottschalk HJ ; Witt H .; Pohle HD . "Efficacy of pyrimethamine/sulfadoxine in the prevention of toxoplasmic encephalitis relapses and Pneumocystis carinii pneumonia in HIV infected patients" . Eur J Clin Microbiol Infect Dis 1993 ; 12(5) : 325-9 .

74

113. Ruf B .; Pohle HD . "Therapie und Prophylaxe der Toxoplasmose bei HIV-Infektion" . AIFO 1995 ; 9 : 479-90 .

114. Sandow D .; Bretschneider R .; Bretschneider M .; Denkmann M .; Müller WA ; Nass W .; Ockert G .; Röpke F .; Teichmann A . "Hochrechnung zur Häufigkeit von primär Toxoplasma-infizierten Schwangeren und konnatalen Toxoplasmosen" . Z Klin Med 1989 ; 44(21) : 1869-73 .

115. Schneider MM ; Hoepelman AI ; Eeftinck Schattenkerk JK ; Nielsen TL ; Van der Graaf Y .; Frissen JP ; Van der Ende IM ; Kolsters AF ; Borleffs JC . "A controlled trial of aerosolized pentamidine or trimethoprim sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. The Dutch AIDS Treatment Group" . N Engl J Med 1992 ; 327(26) : 1836-41 .

116. Scott GL ; Rasbridge MR . "The in vitro action of dapsone and its derivatives on normal and G6PD deficient red cells" . Br J Haematol 1973 ; 24(3) : 307-17 .

117. Shepard CC . "Leprosy today [editorial]" . N Engl J Med 1982 ; 307(26) : 1640-1 .

118. Slavin MA ; Hoy JF ; Stewart K .; Pettinger MB ; Lucas CR ; Kent SJ . "Oral dapsone versus nebulized pentamidine for Pneumocystis carinii pneumonia prophylaxis: an open randomized prospective trial to assess efficacy and haematological toxicity" . AIDS 1992 ; 6(10) : 1169-74 .

119. Stein M .; O'Sullivan P .; Wachtel T .; Fisher A .; Mikolich D .; Sepe S .; Fort G .; Carpenter C .; Skowron G .; Mayer K . "Causes of death in persons with human immunodeficiency virus infection" . Am J Med 1992 ; 93(4) : 387-90 .

120. Stringer SL ; Hudson K .; Blase MA ; Walzer PD ; Cushion MT ; Stringer JR . "Sequence from ribosomal RNA of Pneumocystis carinii compared to those of four fungi suggests an ascomycetous affinity" . J Protozool 1989 ; 36(1) : 14S-16S .

75

121. Swain AF ; Ahmad RA ; Rogers HJ ; Leonard JN ; Fry L . "Pharmacokinetic observations on dapsone in dermatitis herpetiformis" . Br J Dermatol 1983 ; 108(1) : 91-8 .

122. Timm U .; Weidekamm E . "Determination of pyrimethamine in human plasma after administration of fansidar of fansidar mefloquine by means of high performance liquid chromatography with fluorescence detection" . J Chromatogr 1982 ; 230(1) : 107-14 .

123. Torres RA ; Barr M .; Thorn M .; Gregory G .; Kiely S .; Chanin E .; Carlo C .; Martin M . "Thornton J. Randomized trial of dapsone and aerosolized pentamidine for the prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis" . Am J Med 1993 ; 95(6) : 573-83 .

124. Urquhart J . "Role of patient compliance in clinical pharmacokinetics. A review of recent research" . Clin Pharmacokinet 1994 ; 27(3) : 202-15 .

125. Waller E .; Goehrs H . "Dapsone-induced hemolytic anemia in a patient with relapsing polychondritis" . Drug Intell Clin Pharm 1980 ; 14 : 412-4 .

126. Walzer PD . "Pneumocystis carinii new clinical spectrum?" . N Engl J Med 1991 ; 324(4) : 263-5 .

127. Walzer PD ; Foy J .; Steele P .; Kim CK ; White M .; Klein RS ; Otter BA ; Allegra C . "Activities of antifolate, antiviral, and other drugs in an immunosuppressed rat model of Pneumocystis carinii pneumonia" . Antimicrob Agents Chemother 1992 ; 36(9) : 1935-42 .

128. Walzer PD ; Kim CK ; Foy JM ; Linke MJ ; Cushion MT . "Inhibitors of folic acid synthesis in the treatment of experimental Pneumocystis carinii pneumonia" . Antimicrob Agents Chemother 1988 ; 32(1) : 96-103 .

76

129. Waters MF . "New approaches to chemotherapy for leprosy" . Drugs 1983 ; 26(6) : 465-7 .

130. Weidekamm E .; Plozza Nottebrock H .; Forgo I .; Dubach UC . "Plasma concentrations in pyrimethamine and sulfadoxine and evaluation of pharmacokinetic data by computerized curve fitting" . Bull World Health Organ 1982 ; 60(1) : 115-22 .

131. Weiss LM ; Harris C .; Berger M .; Tanowitz HB ; Wittner M . "Pyrimethamine concentrations in serum and cerebrospinal fluid during treatment of acute Toxoplasma encephalitis in patients with AIDS" . J Infect Dis 1988 ; 157(3) : 580-3 .

132. Weiss LM ; Luft BJ ; Tanowitz HB ; Wittner M . "Pyrimethamine concentrations in serum during treatment of acute murine experimental toxoplasmosis" . Am J Trop Med Hyg 1992 ; 46(3) : 288-91 .

133. White NJ . "Clinical pharmacokinetics of antimalarial drugs" . Clin Pharmacokinet 1985 ; 10 : 187-215 .

134. Wiggan EB ; Dennis S .; Reele SB ; Luke DR . "Reassessment of dapsone as a marker of acetylator phenotypes" . Int J Clin Pharmacol Ther Toxicol 1991 ; 29(7) : 262-8 .

135. Wong B .; Gold JW ; Brown AE ; Lange M .; Fried R .; Grieco M .; Mildvan D .; Giron J .; Tapper ML ; Lerner CW ; et al . "Central nervous system toxoplasmosis in homosexual men and parenteral drug abusers" . Ann Intern Med 1984 ; 100(1) : 36-42 .

136. Zuidema J .; Hilbers Modderman ES ; Merkus FW . "Clinical pharmacokinetics of dapsone" . Clin Pharmacokinet 1986 ; 11(4) : 299-315 .

77

137. Zuidema J .; Modderman ES ; Hilbers HW ; Merkus FW ; Huikeshoven H . "Rapid high performance liquid chromatographic method for the determination of dapsone and monoacetyldapsone in biological fluids" . J Chromatogr 1980 ; 182(1) : 130-5 .

© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.